Purinergic receptors: Their role in nociception and primary afferent neurotransmission

Current Opinion in Neurobiology

Volumn 6, Issue 4, 1996, Pages 526-532

  Burnstock, Geoffrey ^a   Wood, John N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE P2X RECEPTOR;

NEUROTRANSMISSION; NOCICEPTION; PAIN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; SYMPATHETIC NERVE;

EID: 0030218060     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(96)80060-2     Document Type: Article

References (63)

1. Burnstock G. A unifying purinergic hypothesis for the initiation of pain. of outstanding interest Lancet. 347:1996;1604-1605 A hypothesis about the sources of ATP involved in triggering different types of nociception, including sympathetic nerves, vascular endothelial cells and tumor cells.
2. 3 mRNA is shown to be high, implying an important role for this receptor in nociception.
3. 3 and its expression in sensory neurons. By co-expressing different P2X subunits in Xenopus oocytes, the authors found that heteromultimeric forms of P2X receptors may better explain the pharmacology of sensory neuron P2X responses.
4. Burnstock G. P2 purinoceptors: historical perspective and classification. P2 Purinoceptors: Localization, Function and Transduction Mechanisms. 1996;1-34 John Wiley and Sons, Chichester, A historical account of the development of the current classification of purinoceptors and of purinergic co-transmission.
5. of outstanding interest Burnstock G. A basis for distinguishing two types of purinergic receptor. Straub RW, Bolis L. Cell Membrane Receptors for Drugs and Hormones: a Multidisciplinary Approach. 1978;107-118 Raven Press, New York.
6. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 46:1994;143-156.
7. 2 purinoceptor? Gen Pharmacol. 16:1985;433-440.
8. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J. 233:1986;309-319.
9. O'Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 12:1991;137-141.
10. xA) as new neurotransmitters. Drug Dev Res. 28:1993;259-262.
11. Abbracchio M, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther. 64:1994;445-475.
12. Burnstock G, King B. The numbering of cloned P2 purinoceptors. Drug Dev Res. 1996;. in press.
13. Holton P. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol (Lond). 145:1959;124-140.
14. Khakh BS, Humphrey PPA, Surprenant A. Electrophysiological properties of P2X purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. of special interest J Physiol (Lond). 484:1995;385-395 An account of the actions of ATP on nodose ganglion cells, which can be used for comparison with properties of recombinant P2X purinoceptors expressed in oocytes.
15. of outstanding interest Thorne P, Housley G. Purinergic signalling in sensory systems. of outstanding interest Semin Neurosci. 8:1996;233-246 A comparative review of the roles of adenosine and ATP in a variety of sensory systems. This is a useful source of information as most of the important earlier landmark papers are quoted.
16. Edwards FA, Gibb AJ, Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature. 359:1992;144-147.
17. 3H]α,β-methylene ATP binding sites in rat brain and spinal cord. Neuroreport. 5:1987;1601-1604.
18. 2x purinoceptors. Naunyn Schmiedebergs Arch Pharmacol. 351:1995;1-12.
19. Bo X, Zhang Y, Nassar M, Burnstock G, Schoepter R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:1995;129-133.
20. Buell G, Lewis C, Collo G, North RA, Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 15:1996;55-62.
21. Nagy JI, Buss M, Daddona PE. On the innervation of trigeminal mesencephalic primary afferent neurons by adenosine deaminase-containing projections from the hypothalamus in the rat. Neuroscience. 17:1986;141-156.
22. Battastini AMO, Oliveira EM, Moreira CM, Bonan CD, Sarkis JF, Dias RD. Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5) from rat brain synaptic plasma membranes. Biochem Mol Biol Int. 37:1995;209-219.
23. Phillis JW, Wu PH. The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol. 16:1981;187-239.
24. Williams M. Purinergic receptors and central nervous system function. Meltzer HY. Psychopharmacology: the Third Generation of Progress. 1987;289-301 Raven Press, New York.
25. Bleehen T, Keele CA. Observations on the algogenic actions of adenosine compounds on human blister base preparation. Pain. 3:1977;367-377.
26. Sylvèn C, Jonzon B, Fredholm BB, Kaijser L. Adenosine injection into the brachial artery produces ischaemia like pain or discomfort in the forearm. Cardiovasc Res. 22:1988;674-678.
27. Biaggioni L, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res. 61:1987;779-786.
28. Watt AH, Lewis DJM, Horne JJ, Smith PM. Reproduction of epigastric pain of duodenal ulceration by adenosine. BMJ. 294:1987;10-12.
29. Lagerqvist BO, Sylvén C, Beermann B, Helmius G, Waldenström A. Intracoronary adenosine causes angina pectoris like pain - an inquiry into the nature of visceral pain. Cardiovasc Res. 8:1990;609-613.
30. Salter MW, Henry JL. Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat. Neuroscience. 22:1987;631-650.
31. Sawynok J, Sweeney MI. The role of purines in nociception. Neuroscience. 32:1989;557-569.
32. 2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J Pharmacol Exp Ther. 250:1989;915-922.
33. Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. of special interest Pain. 61:1995;155-158 A recent study of the treatment of neuropathic pain by infusion of adenosine.
34. Ekblom A, Segerdahl M, Sollevi a. Adenosine increases the cutaneous heat pain threshold in healthy volunteers. Acta Anaesthesiol Scand. 39:1995;717-722.
35. 1) purinoceptors in the spinal cord, including a full discussion of much of the earlier literature.
36. Salter J, De Koninck Y, Henry JL. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol. 41:1993;125-156.
37. Doak GJ, Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur J Pharmacol. 281:1995;311-318.
38. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord. J Pharmacol Exp Ther. 248:1989;447-454.
39. Yang S-W, Zhang Z-H, Chen J-Y, Xie Y-F, Qiao J-T, Dafny N. Morphine and norepinephrine-induced antinociception at the spinal level is mediated by adenosine. Neuroreport. 5:1994;1441-1444.
40. Bean BP, Friel DD. ATP-activated channels in excitable cells. Narahashi T. Ion Channels. 2:1990;169-203 Plenum Publishing Corporation, New York.
41. Bouvier MM, Evans ML, Benham CD. Calcium influx induced by stimulation of ATP receptors in neurones cultured from dorsal root ganglia. Eur J Neurosci. 3:1991;285-291.
42. 2X purinoceptor in cultured neurones of the rat dorsal root ganglia. of outstanding interest Br J Pharmacol. 118:1996;951-957 A characterization of the P2X purinoceptors in dorsal root ganglion neurons and valuable comparison with the characteristics of the P2 purinoceptor subtypes expressed in oocytes or transfected cells.
43. Brake AJ, Wagenbach MJ, Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
44. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. Cloning and expression of the P2X receptor for extracellular ATP reveals a new class of ligand-gated ion channel. Nature. 371:1994;516-519.
45. Huang M, Chalfie M. Gene interactions affecting mechanosensory transduction in Caenorhabditis elegans. Nature. 367:1994;467-470.
46. 6, both of which are also expressed in sensory neurons.
47. North RA. P2X plethore. of special interest Semin Neurosci. 8:1996;187-194 A recent review of the molecular biology and expression of members of the P2X purinoceptor family.
48. Jahr CE, Jessell TM. ATP excites a sub-population of dorsal horn neurons. Nature. 304:1983;730-733.
49. Schott GD. Pain and the sympathetic nervous system. Bannister R, Mathias CJ. Autonomic Failure. 1992;904-917 Oxford University Press, Oxford.
50. McMahon SB. Mechanisms of cutaneous, deep and visceral pain. Wall PD, Melzack R. 3 Textbook of Pain. 1994;129-151 Churchill Livingstone, London.
51. Burnstock G. Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int. 17:1990;357-368.
52. Hannington-Kiff JG. Intravenous regional sympathetic block with guanethidine. Lancet. 1:1974;1019-1020.
53. Yasuda JM. Guanethidine for reflex sympathetic dystrophy. Ann Pharmacother. 28:1994;338-341.
54. Bonezzi C, Miotti D, Bettaglio R, Stephen R. Electromotive administration of guanethidine for treatment of reflex sympathetic dystrophy: a pilot study in eight patients. J Pain Symptom Management. 9:1994;39-43.
55. Levine JD, Goetzl EJ, Basbaum AI. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthrites. Pathol Chronic Inflamm Arthritis. 13:1987;369-383.
56. Malinovsky L, Pac L. Is the Merkel cell a secondary sensory cell? Z Mikrosk Anat Forsch. 99:1985;119-128.
57. Burnstock G. Pathophysiology of migraine: a new hypothesis. Lancet. 1:1981;1397-1399.
58. Burnstock G. Dual control of local blood flow by purines. Dubyak GR, Fedan JA. Biological Actions of Extracellular ATP. 603:1990;31-45 New York Academy of Sciences, New York.
59. Bodin P, Burnstock G. Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia. 51:1995;256-259.
60. Crea F, Pupita G, Galassi AR, El-Tamimi H, Kaski JC, Davies G, Maseri A. Role of adenosine in pathogenesis of anginal pain. Circulation. 81:1990;164-172.
61. Maehara Y, Kusumoto H, Anai H, Kusumoto T, Sugimachi K. Human tumor tissues have higher ATP contents than normal tissues. Clin Chim Acta. 169:1987;341-344.
62. Siems WG, Grune T, Schmidt H, Tikhonov YV, Pimenov AM. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor. Cancer Res. 53:1993;5143-5147.
63. Trams EJ, Kauffman H, Burnstock G. A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol. 87:1980;609-621.